GenapSys: Jason Myers, Hesaam Esfandyarpour
GenapSys has named Jason Myers CEO, effective Feb. 15, 2021, replacing founder Hesaam Esfandyarpour. Myers will also join the board of directors.
Myers comes to GenapSys from Invitae, where he was president of oncology. Prior to that, he was president and CEO of ArcherDx, which he also cofounded, until Invitae acquired the company last October. He also previously held positions at Ion Torrent, and holds a doctorate molecular pharmacology from Stanford University. Myers will continue to serve on Invitae's board of directors.
Esfandyarpour, who served as CEO since 2010, will remain as GenapSys' chairman.